Beyond Primary Psychiatry: Medical Causes of Neuropsychiatric Symptoms and an Interdisciplinary Diagnostic Approach
DOI:
https://doi.org/10.64784/310Palabras clave:
neuropsychiatric manifestations, medical diseases, differential diagnosis, autoimmune encephalitis, delirium, cognitive impairment, psychosis, interdisciplinary approach, neurology, psychiatryResumen
Neuropsychiatric manifestations associated with medical diseases represent a major diagnostic challenge because cognitive, behavioral, affective, psychotic, and consciousness-related symptoms may closely resemble primary psychiatric disorders. This review aimed to analyze the principal medical conditions associated with neuropsychiatric manifestations, identify clinical warning signs that suggest a secondary medical origin, evaluate the diagnostic tools used for differential diagnosis, and examine the role of interdisciplinary management. A descriptive and analytical integrative review was conducted using the Scientific Method as the methodological framework. Twenty scientific publications addressing neurological, autoimmune, endocrine, metabolic, nutritional, infectious, and systemic conditions were analyzed. The most frequently represented etiological group was autoimmune/neurological disorders (40%), followed by endocrine diseases (20%), metabolic/nutritional conditions (15%), other general medical conditions (15%), systemic autoimmune diseases (5%), and infectious conditions (5%). Cognitive impairment was the most frequently identified neuropsychiatric manifestation (75%), followed by behavioral changes (70%), psychosis (65%), mood disturbances (60%), and altered consciousness or delirium (50%). The main clinical red flags were acute or subacute onset (60%), neurological abnormalities (55%), altered consciousness (50%), seizures (45%), and rapid cognitive decline (45%). Laboratory studies and neuroimaging were the most frequently represented diagnostic tools, while neurology, psychiatry, and internal medicine showed the greatest interdisciplinary participation. These findings indicate that the differential diagnosis of neuropsychiatric symptoms should not rely exclusively on psychiatric phenomenology. A structured approach integrating temporal evolution, neurological and systemic warning signs, targeted complementary testing, and interdisciplinary evaluation may improve the recognition of potentially reversible medical causes, facilitate appropriate treatment, and reduce diagnostic delay.
Referencias
• Isaac, M. L., & Larson, E. B. (2014). Medical conditions with neuropsychiatric manifestations. Medical Clinics of North America, 98(5), 1193–1208. https://doi.org/10.1016/j.mcna.2014.06.012
• Wilson, J. E., Mart, M. F., Cunningham, C., Shehabi, Y., Girard, T. D., MacLullich, A. M. J., Slooter, A. J. C., & Ely, E. W. (2020). Delirium. Nature Reviews Disease Primers, 6, 90. https://doi.org/10.1038/s41572-020-00223-4
• Lee, S., Gottlieb, M., Mulhausen, P., Wilbur, J., Reisinger, H. S., Han, J. H., & Carnahan, R. (2020). Recognition, prevention, and treatment of delirium in emergency department: An evidence-based narrative review. American Journal of Emergency Medicine, 38(2), 349–357. https://doi.org/10.1016/j.ajem.2019.158454
• Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., Glaser, C. A., Honnorat, J., Höftberger, R., Iizuka, T., Irani, S. R., Lancaster, E., Leypoldt, F., Prüss, H., Rae-Grant, A., . . . Dalmau, J. (2016). A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology, 15(4), 391–404. https://doi.org/10.1016/S1474-4422(15)00401-9
• Dalmau, J., & Graus, F. (2018). Antibody-mediated encephalitis. The New England Journal of Medicine, 378(9), 840–851. https://doi.org/10.1056/NEJMra1708712
• Dalmau, J., & Graus, F. (2023). Diagnostic criteria for autoimmune encephalitis: Utility and pitfalls for antibody-negative disease. The Lancet Neurology, 22(6), 529–540. https://doi.org/10.1016/S1474-4422(23)00083-2
• Herken, J., & Prüss, H. (2017). Red flags: Clinical signs for identifying autoimmune encephalitis in psychiatric patients. Frontiers in Psychiatry, 8, 25. https://doi.org/10.3389/fpsyt.2017.00025
• Ford, H., Griffith, S., Warren, N., Swayne, A., Blum, S., Butzkueven, H., O’Brien, T. J., Velakoulis, D., Kulkarni, J., & Monif, M. (2022). Psychiatric manifestations of autoimmune encephalitis. Autoimmunity Reviews, 21(9), 103145. https://doi.org/10.1016/j.autrev.2022.103145
• Pollak, T. A., Lennox, B. R., Müller, S., Benros, M. E., Prüss, H., Tebartz van Elst, L., Klein, H., Steiner, J., Frodl, T., Bogerts, B., Tian, L., Groc, L., Hasan, A., Baune, B. T., Endres, D., Haroon, E., Yolken, R., Benedetti, F., Halaris, A., . . . Bechter, K. (2020). Autoimmune psychosis: An international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. The Lancet Psychiatry, 7(1), 93–108. https://doi.org/10.1016/S2215-0366(19)30290-1
• Endres, D., Leypoldt, F., Bechter, K., Hasan, A., Steiner, J., Domschke, K., Wandinger, K.-P., Falkai, P., Arolt, V., Stich, O., Rauer, S., Prüss, H., & Tebartz van Elst, L. (2020). Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: Clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations. European Archives of Psychiatry and Clinical Neuroscience, 270(7), 803–818. https://doi.org/10.1007/s00406-020-01113-2
• Dalmau, J., Armangué, T., Planagumà, J., Radosevic, M., Mannara, F., Leypoldt, F., Geis, C., Lancaster, E., Titulaer, M. J., Rosenfeld, M. R., & Graus, F. (2019). An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: Mechanisms and models. The Lancet Neurology, 18(11), 1045–1057. https://doi.org/10.1016/S1474-4422(19)30244-3
• Feldman, A. Z., Shrestha, R. T., & Hennessey, J. V. (2013). Neuropsychiatric manifestations of thyroid disease. Endocrinology and Metabolism Clinics of North America, 42(3), 453–476. https://doi.org/10.1016/j.ecl.2013.05.005
• Samuels, M. H. (2014). Psychiatric and cognitive manifestations of hypothyroidism. Current Opinion in Endocrinology, Diabetes and Obesity, 21(5), 377–383. https://doi.org/10.1097/MED.0000000000000089
• Starkman, M. N. (2013). Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration. Endocrinology and Metabolism Clinics of North America, 42(3), 477–488. https://doi.org/10.1016/j.ecl.2013.05.010
• Pivonello, R., Simeoli, C., De Martino, M. C., Cozzolino, A., De Leo, M., Iacuaniello, D., Pivonello, C., Negri, M., Pellecchia, M. T., Iasevoli, F., & Colao, A. (2015). Neuropsychiatric disorders in Cushing’s syndrome. Frontiers in Neuroscience, 9, 129. https://doi.org/10.3389/fnins.2015.00129
• Sahu, P., Thippeswamy, H., & Chaturvedi, S. K. (2022). Neuropsychiatric manifestations in vitamin B12 deficiency. Vitamins and Hormones, 119, 457–470. https://doi.org/10.1016/bs.vh.2022.01.001
• Bertsias, G. K., Ioannidis, J. P. A., Aringer, M., Bollen, E., Bombardieri, S., Bruce, I. N., Cervera, R., Dalakas, M., Doria, A., Hanly, J. G., Huizinga, T. W. J., Isenberg, D., Kallenberg, C., Piette, J. C., Schneider, M., Scolding, N., Smolen, J., Stara, A., Tassiulas, I., . . . Boumpas, D. T. (2010). EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: Report of a task force of the EULAR Standing Committee for Clinical Affairs. Annals of the Rheumatic Diseases, 69(12), 2074–2082. https://doi.org/10.1136/ard.2010.130476
• Zimbrean, P. C., & Schilsky, M. L. (2014). Psychiatric aspects of Wilson disease: A review. General Hospital Psychiatry, 36(1), 53–62. https://doi.org/10.1016/j.genhosppsych.2013.08.007
• Ferenci, P. (2017). Diagnosis of Wilson disease. Handbook of Clinical Neurology, 142, 171–180. https://doi.org/10.1016/B978-0-444-63625-6.00014-8
• Elendu, C., Aguocha, C. M., Okeke, C. V., Okoro, C. B., & Peterson, J. C. (2023). HIV-related neurocognitive disorders: Diagnosis, treatment, and mental health implications: A review. Medicine, 102(43), e35652. https://doi.org/10.1097/MD.0000000000035652
